C21 Investments Inc. (CXXIF)
OTCMKTS · Delayed Price · Currency is USD
0.4050
+0.0114 (2.90%)
Oct 27, 2025, 3:52 PM EDT
C21 Investments Revenue
C21 Investments had revenue of $8.55M in the quarter ending June 30, 2025, with 29.67% growth. This brings the company's revenue in the last twelve months to $32.08M, up 11.49% year-over-year. In the fiscal year ending March 31, 2025, C21 Investments had annual revenue of $30.12M with 12.42% growth.
Revenue (ttm)
32.08M
Revenue Growth
+11.49%
P/S Ratio
1.58
Revenue / Employee
232.43K
Employees
138
Market Cap
50.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 30.12M | 3.33M | 12.42% |
| Mar 31, 2024 | 26.79M | -1.50M | -5.29% |
| Jan 31, 2024 | 28.29M | -603.21K | -2.09% |
| Jan 31, 2023 | 28.89M | -4.09M | -12.41% |
| Jan 31, 2022 | 32.98M | -483.09K | -1.44% |
| Jan 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |
C21 Investments News
- 7 weeks ago - C21 Investments Announces Completion of Non-Dilutive Creation and Issuance of Subordinate Voting Shares - Newsfile Corp
- 7 weeks ago - C21 Investments Announces Settlement of Eco Firma Farms Litigation - Newsfile Corp
- 1 year ago - Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close - Benzinga
- 1 year ago - C21 Investments Announces Q2 Earnings Date and Provides Operational Update - Newsfile Corp
- 1 year ago - C21 Investments Provides MCTO Status Update - Newsfile Corp
- 1 year ago - Does Size Matter? These Two Small-Cap Cannabis Stocks Are Masters Of Cash Flow And Credit Management - Benzinga
- 1 year ago - C21 Investments Announces Change to Financial Year-End, Delay in Filing Annual Financial Results and Application for Management Cease Trade Order - Newsfile Corp
- 1 year ago - C21 Announces Closing of C$4 Million Private Placement of Convertible Debenture Units - Newsfile Corp